Novocure Ltd. (NVCR): Price and Financial Metrics

Novocure Ltd. (NVCR): $12.42

0.30 (-2.36%)

POWR Rating

Component Grades








Add NVCR to Watchlist
Sign Up

NVCR Price/Volume Stats

Current price $12.42 52-week high $83.60
Prev. close $12.72 52-week low $10.87
Day low $12.20 Volume 464,788
Day high $12.71 Avg. volume 1,360,934
50-day MA $14.89 Dividend yield N/A
200-day MA $18.83 Market Cap 1.33B

NVCR Stock Price Chart Interactive Chart >

Novocure Ltd. (NVCR) Company Bio

NovoCure Limited is a commercial stage oncology company which develops treatment for solid tumor cancers therapy called the tumor treating fields. The company was founded in 2000 and is based in Saint Helier, Channel Islands.

NVCR Latest News Stream

Event/Time News Detail
Loading, please wait...

NVCR Latest Social Stream

Loading social stream, please wait...

View Full NVCR Social Stream

Latest NVCR News From Around the Web

Below are the latest news stories about NOVOCURE LTD that investors may wish to consider to help them evaluate NVCR as an investment opportunity.

Novocure to Participate in 42nd Annual J.P. Morgan Healthcare Conference

ROOT, Switzerland, December 27, 2023--Novocure (NASDAQ: NVCR) announced today that management will participate in the 42nd Annual J.P. Morgan Healthcare Conference on January 9-10, 2024. William Doyle, Novocure’s Executive Chairman, will speak on behalf of the company and address questions from analysts at 7:30 a.m. PST on Wednesday, January 10, 2024. Mr. Doyle and Ashley Cordova, Novocure’s Chief Financial Officer, will participate in one-on-one meetings with investors throughout the event.

Yahoo | December 27, 2023

7 Nasdaq Stocks Down 59% Set to Soar at Least 141%

Wall Street loves a good comeback story.

Rich Duprey on InvestorPlace | December 13, 2023

15 Best Falling Stocks To Buy Now

In this piece, we will take a look at the 15 best falling stocks to buy now. If you want to skip our overview of the current stock market environment and our coverage of the latest stock market news, then you can skip ahead to 5 Best Falling Stocks To Buy Now. With 2023 coming […]

Yahoo | December 8, 2023

The Top and Bottom Stocks of 2023

Top performing stocks in 2023 included those in the technology sector, taking advantage of developments in AI. The bottom performers included NVCR, which was punished because of its ovarian cancer trials' failure to improve survival rates in patients.

Yahoo | December 4, 2023

Evercore ISI Is Pounding the Table on Rivian (RIVN) Stock With Outperform Rating

Rivian stock is getting a boost on Tuesday after analysts at Evercore ISI weighed in on RIVN shares with a reiterated outperform rating.

William White on InvestorPlace | November 28, 2023

Read More 'NVCR' Stories Here

NVCR Price Returns

1-mo -11.16%
3-mo 0.00%
6-mo -16.19%
1-year -80.68%
3-year -93.55%
5-year -70.58%
YTD -16.81%
2023 -79.65%
2022 -2.30%
2021 -56.61%
2020 105.34%
2019 151.70%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!